Lenvatinib is a tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). It is an anti-tumour medicine, and it is used in treating patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. The medicine is supplied in 10 mg and 4 mg capsules for oral administration. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumour growth, and cancer progression. Lenvatinib price is affordable in India, and this medicine is readily available with multiple generic medicine suppliers. The Indian Pharma is one of the licensed suppliers, supplying drugs globally for more than 7 years.
Emily Jones Real Estate
Tim88
Fletcher Byrd
Haahr Holmes
Co88
Rodriguez Gunn
High Levin
Richard Foley
Accsmaster
Jacobson Mcleod